GDC-0077
Allinich foar wittenskiplik ûndersyk, net foar pasjinten.
Produkt Detail
Produkt Tags
| Pak Grutte | Beskikberens | Priis (USD) |
Gemyske namme:
(S)-2-((2-((S)-4-(difluormethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4] ]oxazepin-9-yl)amino)propanamide
SMILES Koade:
C[C@@H](C(N)=O)NC1=CC=C(C2=NC(N3[C@H](C(F)F)COC3=O)=CN2CCO4)C4=C1
InChi Koade:
InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11) 24) 2 5-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26 )/t9-,12-/m0/s1
InChi Key:
SGEUNORSOZVTOL-CABZTGNLSA-N
Keyword:
GDC-0077; GDC 0077; GDC0077
Oplosberens:DMSO
Opslach:
Beskriuwing:
GDC-0077 is in oraal beskikbere PI3K-ynhibitor mei potinsjele antineoplastyske aktiviteit. GDC-0077 is helle út patint WO 2017001645 A1, formule I.
Doel: PI3K
